Therapy Areas
19 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Thursday that it has entered into a strategic research collaboration with Isomorphic Labs, an AI-first drug design and de...
19 November 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that it has received European Commission approval for VaxRabeo, its next-generation rabies vaccine, for pre-exposure and post-exposure pr...
19 November 2026 - Life sciences company Avacta Therapeutics (AIM:AVCT) on Thursday reported new preclinical data showing that its investigational cancer drug AVA6207 overcame resistance to topoisomerase I inhibitors (TOP1i) in laboratory studies and...
19 November 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ:ANIX) announced on Wednesday that it will work with Curia Global, a contract development and manufacturing organisation (CDMO), to provide formulation development services for Ani...
19 November 2026 - Akagera Medicines Inc, a clinical-stage biopharmaceutical company developing lipid nanoparticle (LNP) therapeutics and vaccines for infectious diseases, announced on Wednesday that the Gates Foundation has expanded its grant suppor...
19 November 2026 - DNV, an EU Notified Body for the In Vitro Diagnostic Medical Devices Regulation (IVDR), announced on Wednesday that it has issued an IVDR certificate to China-based FAMID Biomedical Technology (Tianjin) Co Ltd for its diagnostic te...
18 November 2026 - Norwegian bladder cancer diagnostics company Photocure ASA (OSE: PHO) said on Wednesday that it has signed an agreement with pharmaceutical services provider Clinigen to supply Hexvix through a Named Patient Program (NPP) in more t...